Page last updated: 2024-10-22

aminoglutethimide and Leukemia, Promyelocytic, Acute

aminoglutethimide has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lengfelder, E1
Simon, M1
Haase, D1
Hild, F1
Hehlmann, R1

Other Studies

1 other study available for aminoglutethimide and Leukemia, Promyelocytic, Acute

ArticleYear
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Deutsche medizinische Wochenschrift (1946), 1994, Aug-26, Volume: 119, Issue:34-35

    Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; D

1994